Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis https://t.co/UfS94X3VhY
RT @keinakashima1: 慢性炎症性関節炎患者2050人を対象とした横断研究で,ステロイド投与は,COVID19感染リスクの増加に関連した(調整オッズ比 1.23 [95%CI 1.04-1.44]).逆に生物学的製剤は感染リスクの減少に関連.DMARDSは感染リス…
慢性炎症性関節炎患者2050人を対象とした横断研究で,ステロイド投与は,COVID19感染リスクの増加に関連した(調整オッズ比 1.23 [95%CI 1.04-1.44]).逆に生物学的製剤は感染リスクの減少に関連.DMARDSは感染リスク増加に関連しなかった. Arthritis Research & Therapy https://t.co/6VJuxV4DJ3
RT @RheumNow: Study of 2050 Northern Italian arthritis clinic pts; where 1.1-1.4% of population developed COVID-19. Steroid use was indepen…
RT @RheumNow: Study of 2050 Northern Italian arthritis clinic pts; where 1.1-1.4% of population developed COVID-19. Steroid use was indepen…
RT @RheumNow: Study of 2050 Northern Italian arthritis clinic pts; where 1.1-1.4% of population developed COVID-19. Steroid use was indepen…
Study of 2050 Northern Italian arthritis clinic pts; where 1.1-1.4% of population developed COVID-19. Steroid use was independently associated with increased COVID risk (adj OR 1.23 to 3.20). But Rx w/ ts/bDMARDs had reduced risk (adj OR 0.46). https://t.
AR&T: Impact of corticosteroids & immunosuppr therapies on symptomatic SARS-CoV2 infection in a large cohort of pts w/ chronic inflamm arthritis: "Tx w/ immunomodulatory meds appears safe; GCs may confer increased risk; No independent effects of cs